Rockefeller Capital Management’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding GBIO
Rockefeller Capital Management's GBIO Position: Q1 2026 in Review
Rockefeller Capital Management sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 500 shares — an estimated $2.84K sold.
Rockefeller Capital Management first reported a position in GBIO in Q3 2025 and held it in 2 quarters. The position peaked at $2.84K in Q4 2025. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Rockefeller Capital Management reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Rockefeller Capital Management sold 500 Generation Bio shares in Q1 2026, an estimated $2.84K.
- Rockefeller Capital Management first reported a position in Generation Bio in Q3 2025 and held it in 2 quarters.
- Rockefeller Capital Management's Generation Bio position peaked at $2.84K in Q4 2025.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.